| | | Single nucleotide variant (missense variant) | Hereditary cancer-predisposing syndrome +5 more | |
| | | Indel (frameshift variant) | Congenital sensory neuropathy with selective loss of small myelinated fibers | |
| | | Single nucleotide variant (missense variant) | not specified | |
| | | Microsatellite (inframe_deletion) | Neuroblastoma, susceptibility to, 3 +2 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (splice donor variant) | Lynch syndrome | |
| | | Single nucleotide variant (missense variant) | Aicardi-Goutieres syndrome 7 +1 more | |
| | | Single nucleotide variant (missense variant) | Aicardi-Goutieres syndrome 7 +1 more | |
| | | Single nucleotide variant (missense variant) | not provided +3 more | |
| | | Single nucleotide variant (missense variant +2 more) | Hereditary cancer-predisposing syndrome +3 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant +2 more) | Hereditary cancer-predisposing syndrome +4 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant +2 more) | Familial cancer of breast +4 more | GConflicting classifications of pathogenicity |
| | FANCD2, LOC107303338 (P727L +1 more) | Single nucleotide variant (missense variant) | Fanconi anemia complementation group D2 +2 more | GConflicting classifications of pathogenicity |
| | | Deletion (intron variant) | Biotinidase deficiency | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (missense variant) | Inborn genetic diseases +2 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (missense variant +1 more) | Biotinidase deficiency +1 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant +1 more) | Biotinidase deficiency | |
| | | Single nucleotide variant (missense variant +1 more) | not specified +1 more | |
| | | Single nucleotide variant (missense variant +1 more) | not provided +2 more | |
| | | Single nucleotide variant (missense variant +1 more) | Biotinidase deficiency | |
| | | Single nucleotide variant (missense variant) | Thyroid hormone resistance, generalized, autosomal dominant +3 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (synonymous variant +2 more) | Lynch syndrome 1 | |
| | | Single nucleotide variant (missense variant) | PITUITARY HORMONE DEFICIENCY, COMBINED, 5 | |
| | | Single nucleotide variant (missense variant) | Glycogen storage disease IV, classic hepatic +1 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (missense variant +1 more) | Primrose syndrome | |
| | | Copy number gain | not provided | |
| | CYP21A2, LOC106780800 (L173fs +2 more) | Duplication (frameshift variant) | not provided +1 more | |
| | CYP21A2, LOC106780800 (P298L +2 more) | Single nucleotide variant (missense variant) | Congenital adrenal hyperplasia | |
| | | Single nucleotide variant (missense variant +1 more) | Arginase deficiency | GPathogenic/Likely pathogenic |
| | ARG1, MED23 (T135I +1 more) | Single nucleotide variant (missense variant +2 more) | Arginase deficiency | GPathogenic/Likely pathogenic |
| | ARG1, MED23 (R308Q +2 more) | Single nucleotide variant (missense variant +2 more) | Arginase deficiency | |
| | | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome +2 more | |
| | | Single nucleotide variant (missense variant +1 more) | Lynch syndrome +3 more | |
| | | Single nucleotide variant (missense variant) | Aplastic anemia +1 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant | Pendred syndrome | |
| | | Single nucleotide variant (missense variant) | not specified +1 more | |
| | CNTNAP2, LOC129999529 +1 more | Deletion | Schizoaffective disorder, depressive type | |
| | | Deletion (frameshift variant) | Hereditary cancer-predisposing syndrome +6 more | |
| | | Single nucleotide variant (intron variant) | Hereditary cancer-predisposing syndrome +4 more | |
| | | Single nucleotide variant (missense variant +2 more) | not provided +4 more | |
| | | Single nucleotide variant (missense variant) | Tuberous sclerosis 1 +2 more | |
| | | Single nucleotide variant (missense variant) | Glycogen storage disease, type V +1 more | |
| | | Single nucleotide variant (nonsense) | not provided +2 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (missense variant) | Hereditary cancer-predisposing syndrome +1 more | |
| | | Single nucleotide variant (5 prime UTR variant) | Multiple endocrine neoplasia, type 1 +3 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | not provided +3 more | |
| | | Single nucleotide variant (missense variant) | Peroxisome biogenesis disorder 2B +1 more | |
| | | Single nucleotide variant (missense variant) | Peroxisome biogenesis disorder 2A (Zellweger) +1 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (missense variant) | Phenylketonuria | |
| | | Single nucleotide variant (missense variant) | Breast and/or ovarian cancer +5 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Familial cancer of breast +10 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Hereditary cancer-predisposing syndrome +4 more | GConflicting classifications of pathogenicity |
| | | Deletion (frameshift variant) | Hereditary breast ovarian cancer syndrome +2 more | |
| | | Single nucleotide variant (missense variant) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Single nucleotide variant (missense variant) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Single nucleotide variant (missense variant) | Breast-ovarian cancer, familial, susceptibility to, 2 +6 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (splice acceptor variant) | not specified +11 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (missense variant) | not specified | |
| | | Single nucleotide variant (missense variant) | Newfoundland cone-rod dystrophy +2 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | not provided +4 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | not specified +3 more | GConflicting classifications of pathogenicity |
| | | Copy number gain | not provided | |
| | | Copy number gain | not provided | |
| | | Single nucleotide variant (missense variant +2 more) | Hereditary breast ovarian cancer syndrome +1 more | GConflicting classifications of pathogenicity |
| | | Duplication (frameshift variant +3 more) | Breast-ovarian cancer, familial, susceptibility to, 1 | |
| | | Single nucleotide variant (missense variant +2 more) | not provided +2 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant +2 more) | Hereditary breast ovarian cancer syndrome +1 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (missense variant +2 more) | not provided +4 more | |
| | | Single nucleotide variant (missense variant +2 more) | Hereditary breast ovarian cancer syndrome +4 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (missense variant +1 more) | Hereditary breast ovarian cancer syndrome +1 more | |
| | | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome +3 more | |
| | | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome +4 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant +2 more) | Breast-ovarian cancer, familial, susceptibility to, 1 | |
| | | Indel (missense variant +2 more) | Breast-ovarian cancer, familial, susceptibility to, 1 | |
| | | Single nucleotide variant (missense variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 1 | |
| | | Single nucleotide variant (missense variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 1 | |
| | | Single nucleotide variant (missense variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 1 | |
| | | Single nucleotide variant (missense variant +1 more) | Hereditary breast ovarian cancer syndrome +2 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome +3 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (missense variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 1 | |
| | | Single nucleotide variant (missense variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 1 | |
| | | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome +6 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (missense variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 1 | |
| | | Single nucleotide variant (missense variant +1 more) | Hereditary breast ovarian cancer syndrome +3 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 1 | |
| | | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome +2 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (missense variant +1 more) | Hereditary breast ovarian cancer syndrome +2 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 1 | |
| | | Single nucleotide variant (missense variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 1 | |
| | | Single nucleotide variant (synonymous variant +1 more) | BRCA1-related cancer predisposition | |
| | | Single nucleotide variant (missense variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 1 +4 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome +2 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome +1 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome +2 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (missense variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 1 | |
| | | Single nucleotide variant (missense variant +1 more) | not provided +2 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant +1 more) | Breast neoplasm +5 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 1 | |
| | | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome +3 more | |
| | | Single nucleotide variant (missense variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 1 | |
| | | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome +5 more | |